Cargando…
Personalized Approach to Tissue and Liquid Biopsy after Failure of First-Line EGFR-TKIs: Is There an Issue When Tissue Is Not the Issue? A Case Series
Traditionally, tissue availability from rebiopsy is a prerequisite for adequate sequencing of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in therapy for advanced-stage lung cancer. Tissue biopsy truly is the gold standard for genetic analyses, but in some cases, such as w...
Autores principales: | Bursac, Daliborka, Zarić, Bojan, Kovačević, Tomi, Stojšić, Vladimir, Vagionas, Anastasios, Boukovinas, Ioannis, Tsakiridis, Kosmas, Kosmidis, Christoforos, Sapalidis, Konstantinos, Romanidis, Konstantinos, Courcoutsakis, Nikolaos, Matthaios, Dimitris, Zarogoulidis, Paul, Sardeli, Chrysanthi, Sekerus, Vanesa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215970/ https://www.ncbi.nlm.nih.gov/pubmed/34177521 http://dx.doi.org/10.1159/000515506 |
Ejemplares similares
-
Long Term Respiratory Follow-Up for COVID-19 Patients a Multicenter Study
por: BURSAC, DALIBORKA, et al.
Publicado: (2021) -
Lung cancer biopsies: Comparison between simple 22G, 22G upgraded and 21G needle for EBUS-TBNA
por: Zarogoulidis, Paul, et al.
Publicado: (2020) -
Acute pneumothorax due to immunotherapy administration in non-small cell lung cancer
por: Sardeli, Chrysanthi, et al.
Publicado: (2020) -
Producing the appropriate model and drug for intratumoural ablation
por: Kosmidis, Christoforos, et al.
Publicado: (2020) -
Intratumoral Treatment with Chemotherapy and Immunotherapy for NSCLC with EBUS-TBNA 19G
por: Zarogoulidis, Paul, et al.
Publicado: (2021)